Home › Funds › Duquesne Family Office LLC › NUVB
Duquesne Family Office LLC position in NUVB
NUVATION BIO INC · Health Care
Duquesne Family Office LLC reported holding 2,269,900 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$12.7M, representing 0.34% of its reported portfolio and ranking #47 among its reported holdings. Duquesne Family Office LLC has disclosed NUVB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Duquesne Family Office LLC's NUVB position evolved
Duquesne Family Office LLC first disclosed a stake in NUVB in Q1 2026 at 4,539,800 shares (US$19.5M). The position peaked in Q2 2026 at 4,539,800 shares, worth US$25.8M. Across 3 filings, Duquesne Family Office LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,269,900 shares valued at US$12.7M — a reduction of -2,269,900 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2026 (shares fell 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 4.54M | $19.48M | New |
| Q2 2026 | 4.54M | $25.79M | Hold |
| Q3 2026 | 2.27M | $12.71M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 55 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $145.34M · Q3 2026
- Context Capital Management, LLC 52.00M sh · $53.13M · Q3 2026
- Laurion Capital Management LP 7.70M sh · $43.10M · Q3 2026
- Omega Fund Management, LLC 7.15M sh · $40.05M · Q3 2026
- Jones Hill Capital LP 4.49M sh · $25.13M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.48M · Q3 2026
- Redmile Group, LLC 3.03M sh · $16.97M · Q3 2026
- QVT Financial LP 15.50M sh · $15.93M · Q3 2026
- Knoll Capital Management, LLC 1.60M sh · $8.95M · Q3 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- Nan Fung Group Holdings Ltd 1.33M sh · $7.43M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.11M · Q3 2026
More on Duquesne Family Office LLC
FAQ
How long has Duquesne Family Office LLC held NUVB?
Duquesne Family Office LLC has disclosed NUVB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Duquesne Family Office LLC's current position in NUVB?
As of Q3 2026, Duquesne Family Office LLC holds 2.27M shares of NUVB (NUVATION BIO INC), valued at $12.71M, representing 0.34% of its reported portfolio and ranking #47.
Has Duquesne Family Office LLC been buying or selling NUVB?
In the latest 13F filing (Q3 2026), Duquesne Family Office LLC reduced its position in NUVB. The position peaked in Q2 2026 at 4.54M shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Laurion Capital Management LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.